1-8 of 8
Elise A. Olsen
Close
Sort by
Journal Articles

Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC

Clinical Trials & Observations
Elise A. Olsen, Sean Whittaker, Rein Willemze, Lauren Pinter-Brown, Francine Foss, Larisa Geskin, Lawrence Schwartz, Steven Horwitz, Joan Guitart, John Zic, Youn H. Kim, Gary S. Wood, Madeleine Duvic, Wei Ai, Michael Girardi, Alejandro Gru, Emmanuella Guenova, Emmilia Hodak, Richard Hoppe, Werner Kempf, Ellen Kim, Mary Jo Lechowicz, Pablo Ortiz-Romero, Evangelia Papadavid, Pietro Quaglino, Mark Pittelkow, H. Miles Prince, Jose Antonio Sanches, Makoto Sugaya, Maarten Vermeer, Jasmine Zain, Robert Knobler, Rudolf Stadler, Martine Bagot, Julia Scarisbrick
Journal: Blood
Blood (2022) 140 (5): 419–437.
https://doi.org/10.1182/blood.2021012057
Published: 2022
Journal Articles

Efficacy of Denileukin Diftitox Retreatment In Patients with Cutaneous T-Cell Lymphoma Who Relapsed After Initial Response

Madeleine Duvic, MD, Ann Martin, MD, Elise A. Olsen, MD, David Fivenson, MD, Miles Prince, MD, FRACP, FRCPA
Journal: Blood
Blood (2010) 116 (21): 2863.
https://doi.org/10.1182/blood.V116.21.2863.2863
Published: 2010
Journal Articles

The Systemic Effects of Vorinostat in Patients (Pts) with Cutaneous T-Cell Lymphoma (CTCL): Post-Hoc Analyses in Pts with High Blood Tumor Burden.

Madeleine Duvic, MD, Youn H Kim, MD, Timothy M Kuzel, MD, Theresa R Pacheco, MD, Francine M Foss, Sareeta Parker, Syed Rizvi, Cong Chen, Jean Marie Arduino, ScD, Elise A. Olsen, MD
Journal: Blood
Blood (2009) 114 (22): 1709.
https://doi.org/10.1182/blood.V114.22.1709.1709
Published: 2009
Journal Articles

Complete Responses with Denileukin Diftitox in Cutaneous T-Cell Lymphoma Studies.

Francine Foss, MD, Madeleine Duvic, MD, Elise A. Olsen, MD, Anna Kozlovski, Pharm, D
Journal: Blood
Blood (2009) 114 (22): 3745.
https://doi.org/10.1182/blood.V114.22.3745.3745
Published: 2009
Journal Articles

Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) Provides Prolonged Safety and Clinical Benefit to Patients with Advanced Cutaneous T-Cell Lymphoma (CTCL).

Madeleine Duvic, Elise A. Olsen, Debra Breneman, Theresa R. Pacheco, Sareeta Parker, Eric C. Vonderheid, Justin L. Ricker, Syed Rizvi, Cong Chen, Kathleen Boileau, Paulette Cooley, Larisa J. Geskin
Journal: Blood
Blood (2007) 110 (11): 2582.
https://doi.org/10.1182/blood.V110.11.2582.2582
Published: 2007
Journal Articles

TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC)

Youn H. Kim, Rein Willemze, Nicola Pimpinelli, Sean Whittaker, Elise A. Olsen, Annamari Ranki, Reinhard Dummer, Richard T. Hoppe
Journal: Blood
Blood (2007) 110 (2): 479–484.
https://doi.org/10.1182/blood-2006-10-054601
Published: 2007
Includes: Supplemental data
Journal Articles

Vorinostat (Suberoylanilide Hydroxamic Acid, SAHA) Provides Prolonged Clinical Benefit to Advanced Cutaneous T-Cell Lymphoma Patients: Updated Results of the Phase IIb Multicenter Clinical Trial.

Madeleine Duvic, MD, Youn H. Kim, MD, Timothy M. Kuzel, MD, Theresa R. Pacheco, MD, Francine M. Foss, MD, Sareeta Parker, MD, Stanley R. Frankel, MD, Cong Chen, PhD, Justin L. Ricker, MD, PhD, Jean Marie Arduino, PhD, Sophia Randolph, MD, PhD, Victoria M. Richon, PhD, Elise A. Olsen, MD
Journal: Blood
Blood (2006) 108 (11): 399.
https://doi.org/10.1182/blood.V108.11.399.399
Published: 2006
Journal Articles

Intravenous Forodesine (BCX-1777), a Novel Purine Nucleoside Phosphorylase (PNP) Inhibitor, Demonstrates Clinical Activity in Patients with Refractory Cutaneous T-Cell Lymphoma.

Madeleine Duvic, MD, Francine M. Foss, MD, Elise A. Olsen, MD, Andres Forero-Torres, MD, J. Claude Bennett, MD, Shanta Bantia, PhD, J. Michael Kilpatrick, PhD
Journal: Blood
Blood (2004) 104 (11): 2491.
https://doi.org/10.1182/blood.V104.11.2491.2491
Published: 2004